Mixed Results for Oral Multiple-Sclerosis Drug - WSJ.com

OrganizedWisdom MS OW Health

Also Shared By:

WSJ Health

Teva reports favorable Laquinimod trial results - Globes

globes.co.il — “Teva reports favorable Laquinimod trial results - Globes” View full resource at globes.co.il

Most Recently Shared on March 18, 2012 at 6:21 pm By:

Teva reports favorable Laquinimod trial results: The oral multiple sclerosis drug reduced inflammatory disease a... http://t.co/3j4okZET

2 months ago...

FierceBiotech Health News

Active Biotech gets boost from late-stage oral MS program - FierceBiotech

fiercebiotech.com — “Active Biotech's ($ACTI) shares jumped after its partner Teva Pharmaceutical ($TEVA) touted results of a late-stage trial for an oral multiple sclerosis drug under development with Active. While Read more...” View full resource at fiercebiotech.com

Most Recently Shared on March 16, 2012 at 1:28 pm By:

Active Biotech gets boost from late-stage oral MS program http://t.co/2VmTT4G7 $ACTI $TEVA #biotech

2 months ago...

Phase III Study of Teva's Oral Laquinimod Published in the New England Journal of Medicine Demonstrates Clinical Benefits for Multiple Sclerosis Patients - Drugs.com MedNews

drugs.com — “Phase III ALLEGRO study results showed laquinimod reduced the annual rate of relapses, slowed the progression of disability, and decreased brain tissue loss Laq” View full resource at drugs.com

Most Recently Shared on March 15, 2012 at 1:06 pm By:

Phase III Study of Teva's Oral Laquinimod Published in the New England Journal of Medicine Demonstrates Cl... http://t.co/7h6BYAaN #drug

2 months ago...

Your Total Health Health Site

Experimental MS Drug Shows Promise - iVillage

ivillage.com — “WEDNESDAY, Oct. 5 (HealthDay News) -- A new oral drug for relapsing forms of multiple sclerosis appears to reduce relapse rates and disability progression, according to the results of a so-called phase 3 trial. The experimental drug, terifluno” View full resource at ivillage.com

Most Recently Shared on October 8, 2011 at 7:25 pm By:

Experimental MS Drug Shows Promise http://ow.ly/6PAxe

7 months ago...

Oral Laquinimod for Multiple Sclerosis Treatment Significantly Reduced Disease Activity and Disability Progression While Providing Good Safety and Tolerability - Drugs.com MedNews

drugs.com — “Teva Announces Updated Time For Webcast To Discuss Study Results On April 11th, 7 00 p.m. EDT Phase III ALLEGRO study met primary endpoint and key secondary end” View full resource at drugs.com

Most Recently Shared on April 12, 2011 at 3:06 pm By:

Oral Laquinimod for Multiple Sclerosis Treatment Significantly Reduced Disease Activity and Disability Pro... http://bit.ly/fxxQkw #drug

Teva Announces Webcast on Results from Phase III ALLEGRO Study of Oral Laquinimod in Multiple Sclerosis - Drugs.com MedNews

drugs.com — “Apr 8, 2011 - Teva Pharmaceutical Industries Ltd. (NASDAQ TEVA) will host an audio webcast on Thursday, April 14 at 4 15 p.m. EDT to present the results from th” View full resource at drugs.com

Most Recently Shared on April 11, 2011 at 7:08 pm By:

Teva Announces Webcast on Results from Phase III ALLEGRO Study of Oral Laquinimod in Multiple Sclerosis: J... http://bit.ly/gATjPE #drug

OrganizedWisdom MS OW Health

Biogen MS Pill Clears Late-Stage Test - TheStreet

thestreet.com — “Biogen announces positive results from a phase III study of its oral MS drug BG-12.” View full resource at thestreet.com

Most Recently Shared on April 11, 2011 at 2:30 pm By:

Biogen MS Pill Clears Late-Stage Test: Updated with new information, analyst quotes, new stock price. WESTON, Ma... http://bit.ly/gxcj7a

ScienceintheTriangle Science Enthusiast

Biogen MS Pill Clears Late-Stage Test - TheStreet

thestreet.com — “Biogen announces positive results from a phase III study of its oral MS drug BG-12.” View full resource at thestreet.com

Most Recently Shared on April 11, 2011 at 1:34 pm By:

Biogen says its MS pill cleared late-stage test, but doesn't release details. (TheStreet) http://bit.ly/eYoa0a #SITT

Biogen Idec Announces Positive Top-Line Results from the First Phase 3 Trial Investigating Oral BG-12 (DIMETHYL FUMARATE) in Multiple Sclerosis - Drugs.com MedNews

drugs.com — “- DEFINE Study Achieves Primary and All Secondary Endpoints for Both Study Doses - - Full Data to Be Presented at a Future Medical Meeting - Apr 11, 2011 - Biog” View full resource at drugs.com

Most Recently Shared on April 11, 2011 at 12:04 pm By:

Biogen Idec Announces Positive Top-Line Results from the First Phase 3 Trial Investigating Oral BG-12 (DIM... http://bit.ly/ebzoNt #drug

John Carroll Health Communicator

Biogen Idec Announces Positive Top-Line Results from the First Phase 3 Trial Investigating Oral BG-12 (DIMETHYL FUMARATE) in Multiple Sclerosis

vancouversun.com — “Biogen Idec Announces Positive Top-Line Results from the First Phase 3 Trial Investigating Oral BG-12” View full resource at vancouversun.com

Most Recently Shared on April 11, 2011 at 11:23 am By:

Biogen's MS drug hits primary, all secondary endpoints in 1st of two Ph3s. Here's the PR: http://bit.ly/eTG42m

OrganizedWisdom MS OW Health

Oral drug approved for relapsing multiple sclerosi... [Am J Health Syst Pharm. 2010] - PubMed result

ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov

Most Recently Shared on October 25, 2010 at 4:10 am By:

Oral drug approved for relapsing multiple sclerosis.: Authors: Thompson CA PMID: 20966138 [PubMed - in pr... http://bit.ly/93zu7L

Lisa Emrich Patient Expert

Brass and Ivory: NEJM publishes studies for two Oral MS drugs.

brassandivory.blogspot.com — “Support and advice for living and coping with multiple sclerosis and rheumatoid arthritis. Read about one woman\” View full resource at brassandivory.blogspot.com

Most Recently Shared on January 21, 2010 at 10:44 pm By:

NEJM publishes studies for two Oral MS drugs.: Yesterday, the New England Journal of Medicine published results fr... http://bit.ly/7DI7FF

Little pill means big news in the treatment of MS

eurekalert.org — “A new drug for multiple sclerosis promises to change the lives of the 100,000 people in the UK who have the condition, say researchers at Queen Mary, University of London. A major trial of the oral drug Cladribine -- results of which are published in the NEJM on Jan. 20, 2010 -- has shown that it significantly reduces relapse and deterioration of the disease, and goes a long way to eliminating the unpleasant side effects associated with existing therapies.” View full resource at eurekalert.org

Most Recently Shared on January 21, 2010 at 10:33 am By:

Stephen Roberts, MD Physician and Doctor

Little pill big news 4 #MS - Cladribine 8x/yr => 55% drop relapse & 30% less progression #MultipleSclerosis http://bit.ly/7JwIMw

medical_tweets Health News

BBC News - Hope for MS pill after cladribine and fingolimod trials

news.bbc.co.uk — “Oral drugs to treat multiple sclerosis could become available in 2011 after promising results in two trials.” View full resource at news.bbc.co.uk

Most Recently Shared on January 20, 2010 at 11:39 pm By:

Trials spark hope of pill for MS Oral drugs to treat multiple sclerosis could become available in 2011 after promisin.. http://bit.ly/7XTgY8

LA Times Health News Health News

Oral multiple sclerosis drug shows promise | Booster Shots | Los Angeles Times

latimesblogs.latimes.com — “A large study on a new oral medication for multiple sclerosis has yielded promising results both in terms of how well the drug works and its safety, according to a study published today in the New England Journal of Medicine....” View full resource at latimesblogs.latimes.com

Most Recently Shared on January 20, 2010 at 10:17 pm By:

Oral multiple sclerosis drug shows promise http://bit.ly/4EZ6K9